N-glycolylneuraminic acid in the pathogenesis and progression of rheumatoid arthr
Ended Project Grant Awarded
- Award ID
- R43AR056166
- Recipient
-
Siamab Therapeutics, Inc. UEI DJM5GUE2NWD7
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $152,526
Award facts
- Assistance listing
- 93.701 Trans-NIH Recovery Act Research Support
- Completion date
- Place of performance
- Anaheim, CA 92801, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43AR056166?
R43AR056166 was awarded to Siamab Therapeutics, Inc. by National Institutes of Health (Department of Health and Human Services) on September 30, 2009.
How much is award R43AR056166 worth?
$152,526 has been obligated on R43AR056166.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award